1. Home
  2. FDP vs AUPH Comparison

FDP vs AUPH Comparison

Compare FDP & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fresh Del Monte Produce Inc.

FDP

Fresh Del Monte Produce Inc.

HOLD

Current Price

$41.11

Market Cap

2.0B

ML Signal

HOLD

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$15.46

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FDP
AUPH
Founded
1886
1993
Country
Cayman Islands
Canada
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
FDP
AUPH
Price
$41.11
$15.46
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$17.25
AVG Volume (30 Days)
187.0K
946.4K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
2.89%
N/A
EPS Growth
N/A
5075.00
EPS
1.88
2.07
Revenue
$4,322,300,000.00
$283,055,000.00
Revenue This Year
N/A
$17.54
Revenue Next Year
$3.14
$15.74
P/E Ratio
$22.37
$7.47
Revenue Growth
0.98
20.38
52 Week Low
$31.85
$7.29
52 Week High
$43.58
$16.88

Technical Indicators

Market Signals
Indicator
FDP
AUPH
Relative Strength Index (RSI) 48.09 48.47
Support Level $40.04 $14.56
Resistance Level $43.06 $16.32
Average True Range (ATR) 0.89 0.51
MACD -0.03 -0.13
Stochastic Oscillator 35.96 30.83

Price Performance

Historical Comparison
FDP
AUPH

About FDP Fresh Del Monte Produce Inc.

Fresh Del Monte Produce Inc is an integrated producer, marketer & distributor of fresh-cut fruit & vegetables. It operates in three segments, Fresh and value-added products segment, which includes pineapples, fresh-cut fruit, fresh-cut vegetables, melons, vegetables, non-tropical fruit, other fruit and vegetables, avocados, and prepared foods, Banana segment & Other products and services segment, including the third-party freight & logistic services business & the Jordanian poultry and meats business. The majority is from the Fresh and value-added products segment. Geographically, it operates in North America, Europe, Asia, the Middle East, and Other, out of which the highest is from North America.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: